Your browser doesn't support javascript.
loading
Current status and vision of local pharmaceutical industries in Saudi Arabia: The focus on nanomedicines.
Halwani, Abdulrahman A; Balkhi, Bander; Alamoudi, Abdullah A; Almozain, Nada H; Alajmi, Areej M; Noorwali, Abdulwahab; Badr, Moutaz Y; Noor, Ahmad O; Bagalagel, Alaa; Tawfik, Essam A.
Afiliación
  • Halwani AA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Balkhi B; Regenerative Medicine Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alamoudi AA; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Almozain NH; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alajmi AM; Kyowa Kirin International Company, Riyadh, Saudi Arabia.
  • Noorwali A; Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
  • Badr MY; Regenerative Medicine Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Noor AO; Department of Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Bagalagel A; Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Tawfik EA; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Riyadh, Saudi Arabia.
Saudi Pharm J ; 31(8): 101674, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37448843
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita